Search > Results
You searched for: EV210076 (EV-TRACK ID)
Showing 1 - 6 of 6
Showing 1 - 6 of 6
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV210076 | 1/6 | Rattus norvegicus | Urine |
(d)(U)C Filtration |
Hinzman CP | 2022 | 67% | |
Study summaryFull title
All authors
Hinzman CP, Jayatilake M, Bansal S, Fish BL, Li Y, Zhang Y, Bansal S, Girgis M, Iliuk A, Xu X, Fernandez JA, Griffin JH, Ballew EA, Unger K, Boerma M, Medhora M, Cheema AK
Journal
J Transl Med
Abstract
Urinary extracellular vesicles (EVs) are a source of biomarkers with broad potential applications ac (show more...)
EV-METRIC
67% (94th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Urine
Sample origin
Control condition
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Filtration Protein markers
EV: TSG101/ ANXA5/ CD81/ Alix/ Flotillin1/ EpCAM/ CD63
non-EV: GM130 Proteomics
no
Show all info
Study aim
New methodological development/Biomarker/Identification of content (omics approaches)
Sample
Species
Rattus norvegicus
Sample Type
Urine
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 800 g and 10,000 g
Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: rotor type
SW 28
Pelleting: speed (g)
120.000
Filtration steps
0.22µm or 0.2µm
Size-exclusion chromatography
Resin type
Characterization: Protein analysis
Protein Concentration Method
BCA
Western Blot
Detected EV-associated proteins
Flotillin1/ CD63/ EpCAM/ ANXA5/ TSG101/ Alix/ CD81
Detected contaminants
GM130
Characterization: Lipid analysis
Yes
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
135
EV concentration
Yes
EM
EM-type
Cryo-EM
Image type
Close-up
|
||||||||
EV210076 | 4/6 | Rattus norvegicus | Urine |
(d)(U)C Filtration |
Hinzman CP | 2022 | 67% | |
Study summaryFull title
All authors
Hinzman CP, Jayatilake M, Bansal S, Fish BL, Li Y, Zhang Y, Bansal S, Girgis M, Iliuk A, Xu X, Fernandez JA, Griffin JH, Ballew EA, Unger K, Boerma M, Medhora M, Cheema AK
Journal
J Transl Med
Abstract
Urinary extracellular vesicles (EVs) are a source of biomarkers with broad potential applications ac (show more...)
EV-METRIC
67% (94th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Urine
Sample origin
13 Gy ionizing radiation
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Filtration Protein markers
EV: TSG101/ CD63/ CD81/ ANXA5/ Alix/ Flotillin1/ EpCam
non-EV: GM130 Proteomics
no
Show all info
Study aim
New methodological development/Biomarker/Identification of content (omics approaches)
Sample
Species
Rattus norvegicus
Sample Type
Urine
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 800 g and 10,000 g
Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: rotor type
SW 28
Pelleting: speed (g)
120.000
Filtration steps
0.22µm or 0.2µm
Size-exclusion chromatography
Resin type
Characterization: Protein analysis
Protein Concentration Method
BCA
Western Blot
Detected EV-associated proteins
Flotillin1/ Alix/ EpCam/ ANXA5/ CD63/ TSG101/ CD81
Detected contaminants
GM130
Characterization: Lipid analysis
Yes
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
134.9
EV concentration
Yes
EM
EM-type
Cryo-EM
Image type
Close-up
|
||||||||
EV210076 | 2/6 | Rattus norvegicus | Urine |
UF qEV SEC (non-commercial) |
Hinzman CP | 2022 | 63% | |
Study summaryFull title
All authors
Hinzman CP, Jayatilake M, Bansal S, Fish BL, Li Y, Zhang Y, Bansal S, Girgis M, Iliuk A, Xu X, Fernandez JA, Griffin JH, Ballew EA, Unger K, Boerma M, Medhora M, Cheema AK
Journal
J Transl Med
Abstract
Urinary extracellular vesicles (EVs) are a source of biomarkers with broad potential applications ac (show more...)
EV-METRIC
63% (92nd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Urine
Sample origin
Control condition
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Ultrafiltration
Commercial method Size-exclusion chromatography (non-commercial) Protein markers
EV: TSG101/ ANXA5/ CD81/ Alix/ Flotillin1/ EpCAM/ CD63
non-EV: GM130 Proteomics
no
Show all info
Study aim
New methodological development/Biomarker/Identification of content (omics approaches)
Sample
Species
Rattus norvegicus
Sample Type
Urine
Separation Method
Ultra filtration
Cut-off size (kDa)
100
Membrane type
Regenerated cellulose
Commercial kit
qEV
Size-exclusion chromatography
Total column volume (mL)
3.5
Sample volume/column (mL)
0.15
Resin type
Not Specified
Characterization: Protein analysis
Protein Concentration Method
BCA
Western Blot
Detected EV-associated proteins
Flotillin1/ CD63/ EpCAM/ ANXA5/ TSG101/ Alix/ CD81
Detected contaminants
GM130
Characterization: Lipid analysis
Yes
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
156.5
EV concentration
Yes
EM
EM-type
Cryo-EM
Image type
Close-up
|
||||||||
EV210076 | 3/6 | Rattus norvegicus | Urine | Other/ EVTrap | Hinzman CP | 2022 | 63% | |
Study summaryFull title
All authors
Hinzman CP, Jayatilake M, Bansal S, Fish BL, Li Y, Zhang Y, Bansal S, Girgis M, Iliuk A, Xu X, Fernandez JA, Griffin JH, Ballew EA, Unger K, Boerma M, Medhora M, Cheema AK
Journal
J Transl Med
Abstract
Urinary extracellular vesicles (EVs) are a source of biomarkers with broad potential applications ac (show more...)
EV-METRIC
63% (92nd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Urine
Sample origin
Control condition
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Commercial method
Protein markers
EV: TSG101/ CD63/ CD81/ Alix/ Flotillin1/ EpCam/ ANXA5
non-EV: GM130 Proteomics
no
Show all info
Study aim
New methodological development/Biomarker/Identification of content (omics approaches)
Sample
Species
Rattus norvegicus
Sample Type
Urine
Separation Method
Commercial kit
Other/ EVTrap
Size-exclusion chromatography
Resin type
Characterization: Protein analysis
Protein Concentration Method
BCA
Western Blot
Detected EV-associated proteins
Flotillin1/ Alix/ CD63/ TSG101/ EpCam/ ANXA5/ CD81
Detected contaminants
GM130
Characterization: Lipid analysis
Yes
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
115.9
EV concentration
Yes
EM
EM-type
Cryo-EM
Image type
Close-up
|
||||||||
EV210076 | 5/6 | Rattus norvegicus | Urine |
UF qEV SEC (non-commercial) |
Hinzman CP | 2022 | 63% | |
Study summaryFull title
All authors
Hinzman CP, Jayatilake M, Bansal S, Fish BL, Li Y, Zhang Y, Bansal S, Girgis M, Iliuk A, Xu X, Fernandez JA, Griffin JH, Ballew EA, Unger K, Boerma M, Medhora M, Cheema AK
Journal
J Transl Med
Abstract
Urinary extracellular vesicles (EVs) are a source of biomarkers with broad potential applications ac (show more...)
EV-METRIC
63% (92nd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Urine
Sample origin
13 Gy ionizing radiation
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Ultrafiltration
Commercial method Size-exclusion chromatography (non-commercial) Protein markers
EV: TSG101/ ANXA5/ CD63/ Alix/ CD81/ Flotillin1/ EpCam
non-EV: GM130 Proteomics
no
Show all info
Study aim
New methodological development/Biomarker/Identification of content (omics approaches)
Sample
Species
Rattus norvegicus
Sample Type
Urine
Separation Method
Ultra filtration
Cut-off size (kDa)
100
Membrane type
Regenerated cellulose
Commercial kit
qEV
Size-exclusion chromatography
Total column volume (mL)
3.5
Sample volume/column (mL)
0.15
Resin type
Not Specified
Characterization: Protein analysis
Protein Concentration Method
BCA
Western Blot
Detected EV-associated proteins
Flotillin1/ EpCam/ ANXA5/ CD63/ TSG101/ Alix/ CD81
Detected contaminants
GM130
Characterization: Lipid analysis
Yes
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
144.4
EV concentration
Yes
EM
EM-type
Cryo-EM
Image type
Close-up
|
||||||||
EV210076 | 6/6 | Rattus norvegicus | Urine | Other/ EVTrap | Hinzman CP | 2022 | 63% | |
Study summaryFull title
All authors
Hinzman CP, Jayatilake M, Bansal S, Fish BL, Li Y, Zhang Y, Bansal S, Girgis M, Iliuk A, Xu X, Fernandez JA, Griffin JH, Ballew EA, Unger K, Boerma M, Medhora M, Cheema AK
Journal
J Transl Med
Abstract
Urinary extracellular vesicles (EVs) are a source of biomarkers with broad potential applications ac (show more...)
EV-METRIC
63% (92nd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Urine
Sample origin
13 Gy ionizing radiation
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Commercial method
Protein markers
EV: TSG101/ CD63/ CD81/ ANXA5/ Alix/ Flotillin1/ EpCam
non-EV: GM130 Proteomics
no
Show all info
Study aim
New methodological development/Biomarker/Identification of content (omics approaches)
Sample
Species
Rattus norvegicus
Sample Type
Urine
Separation Method
Commercial kit
Other/ EVTrap
Characterization: Protein analysis
Protein Concentration Method
BCA
Western Blot
Detected EV-associated proteins
Flotillin1/ Alix/ EpCam/ ANXA5/ TSG101/ CD63/ CD81
Detected contaminants
GM130
Characterization: Lipid analysis
Yes
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
125.2
EV concentration
Yes
EM
EM-type
Cryo-EM
Image type
Close-up
|
||||||||
1 - 6 of 6 |
EV-TRACK ID | EV210076 | |||||
---|---|---|---|---|---|---|
species | Rattus norvegicus | |||||
sample type | Urine | |||||
condition | Control condition | 13 Gy ionizing radiation | Control condition | Control condition | 13 Gy ionizing radiation | 13 Gy ionizing radiation |
separation protocol | dUC/ Filtration | dUC/ Filtration | Ultrafiltration/ qEV/ Size-exclusion chromatography (non-commercial) | Other/ EVTrap | Ultrafiltration/ qEV/ Size-exclusion chromatography (non-commercial) | Other/ EVTrap |
Exp. nr. | 1 | 4 | 2 | 3 | 5 | 6 |
EV-METRIC % | 67 | 67 | 63 | 63 | 63 | 63 |